Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2019 | Cell-Free DNA for GI therapy personalization

John Strickler • 29 Sep 2019
ESMO 2019
Colorectal Cancer Gastrointestinal Cancer

John Strickler, MD, Duke Cancer Center, Durham, NC, discusses a combined analysis from Japan and the United States investigating the use of Cell-Free DNA to detect focal versus non-focal MET amplification in metastatic colorectal cancer patients. This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

More from John Strickler

1:25
Real-world treatment patterns for HER2-amplified colorectal cancer
John Strickler • 21 Oct 2023
0:44
Using ctDNA to identify mutations in colorectal cancer
John Strickler • 21 Oct 2023
0:58
MOUNTAINEER: clinical relevance of genomic profiling for tucatinib + trastuzumab treatment in mCRC
John Strickler • 21 Oct 2023
2:28
MOUNTAINEER: impact of genomic alterations on tucatinib plus trastuzumab activity in mCRC
John Strickler • 21 Oct 2023

Related Videos

1:53
Important pathophysiological determinants of elevated cirDNA post-surgery
Alain Thierry • 9 Apr 2024
0:47
Emerging molecular drivers and biomarker targets in gastroesophageal cancers
Tatsuhiro Shibata • 9 Apr 2024
0:52
DRP-104 with durvalumab in fibrolamellar hepatocellular carcinoma
Marina Baretti • 9 Apr 2024
1:06
The emerging role of cancer vaccines in treating liver cancer
Marina Baretti • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals